Transcatheter aortic valve implantation ... for mitral repair have been conducted with disappointing results due to anatomical incongruities, technical difficulties with current-generation devices ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system ... The company expects to present results from the ENCIRCLE pivotal trial ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

April 14, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter ...

Laplace Interventional, a US-based medical device company focusing on transcatheter ... of valve replacement procedures. The largest markets for these devices include aortic and mitral valve ...

Two state-of-the-art new technologies for transcatheter tricuspid valve replacements is expanding advanced heart care with ...

Frequently, rheumatic mitral stenosis or aortic valve disease is also present ... mitral valve repair has been unsuccessful. (Otto CM, et al. Circulation;2020;55f(e126).) Mitral transcatheter ...